Showing 7481-7490 of 21424 results for "".
- New Cardiovascular Risk Tool Could Guide Who Needs Medication for High Blood Pressurehttps://reachmd.com/news/new-cardiovascular-risk-tool-could-guide-who-needs-medication-for-high-blood-pressure/2467724/(Science Photo Library via Getty Images) For years, the question of whether to take medication to lower high blood pressure had been partly answered by a tool that calculated someone's 10-year risk of having a heart attack or stroke.<
- York Researchers Make Breakthrough in Bid to Develop Vaccines and Drugs for Neglected Tropical Diseasehttps://reachmd.com/news/york-researchers-make-breakthrough-in-bid-to-develop-vaccines-and-drugs-for-neglected-tropical-disease/2467722/Scientists have developed a new, safe and effective way to infect volunteers with the parasite that causes leishmaniasis and measure the body’s immune response, bringing a vaccine for the neglected tropical disease a step closer. The breakthrough, by a team from the Univer
- WHO Calls Emergency Committee on Mpox Spreadhttps://reachmd.com/news/who-calls-emergency-committee-on-mpox-spread/2467727/The World Health Organization's chief announced Wednesday he was urgently convening an expert committee to advise on whether the growing mpox outbreak in Africa should be declared an international emergency. Since last September, cases have surged in the Democratic
- CAR T Cells in Lupus: Promising Results at EULAR 2024 and Emergence of Chinahttps://reachmd.com/news/car-t-cells-in-lupus-promising-results-at-eular-2024-and-emergence-of-china/2467731/At the recent European Alliance of Associations for Rheumatology (EULAR) 2024 conference, chimeric antigen receptor (CAR) T-cell modalities in autoimmune diseases, including systemic lupus erythematosus (SLE) and lupus nephritis (LN), was featured as a key topic. This modality’
- Scientists Probe Molecular Cause of COVID-19-Related Diarrhea, Revealing Potential Treatmentshttps://reachmd.com/news/scientists-probe-molecular-cause-of-covid-19-related-diarrhea-revealing-potential-treatments/2467691/Working with human stem cells that form a kind of "mini intestine-in-a-dish," Johns Hopkins Medicine scientists say they have found several molecular mechanisms for COVID-19-related diarrhea, suggesting potential ways to control it. Details of the experiments in a model o
- Ketogenic Diet Reduces Friendly Gut Bacteria and Raises Cholesterol Levelshttps://reachmd.com/news/ketogenic-diet-reduces-friendly-gut-bacteria-and-raises-cholesterol-levels/2467695/A study from the University of Bath reveals that ketogenic low-carbohydrate diets can increase cholesterol levels and reduce beneficial gut bacteria, specifically Bifidobacterium.
- Exposure to Wildfire Smoke May Affect Patients Undergoing Surgeryhttps://reachmd.com/news/exposure-to-wildfire-smoke-may-affect-patients-undergoing-surgery/2467697/CHICAGO – Nearly 100 wildfires are currently raging throughout the country, burning more than 2 million acres. The rising frequency of these fires poses a special concern for anesthesiologists – the potential for increased rates
- AI Detects Pediatric Eye Diseases via Mobile Photoshttps://reachmd.com/news/ai-detects-pediatric-eye-diseases-via-mobile-photos/2467703/About The Study: In this cross-sectional study, the artificial intelligence (AI) model demonstrated strong performance in accurately identifying myopia, strabismus, and ptosis using only smartphone images. These results suggest that such a model could facilitate the early detection
- Study Shows Seasonality in People's Moral Valueshttps://reachmd.com/news/study-shows-seasonality-in-peoples-moral-values/2467706/A new UBC study has revealed regular seasonal shifts in people’s moral values. The finding has potential implications for politics, law and health—including the timing of elections and court cases, as well as public response to a health crisis. The research
- AffyImmune Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AIC100 in Recurrent Anaplastic Thyroid Cancerhttps://reachmd.com/news/affyimmune-receives-fda-regenerative-medicine-advanced-therapy-rmat-designation-for-aic100-in-recurrent-anaplastic-thyroid-cancer/2467599/RMAT designation follows FDA’s review of available preliminary clinical evidence that AIC100 has the potential to address unmet medical need in recurrent anaplastic thyroid cancer (ATC)RMAT designation enables increased dialogue with the FDA to s